Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Kunming Institute Of Botany Chinese Academy Of Sciences has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner within 1 distinct art unit. This indicates a very concentrated prosecution profile where all current USPTO interaction is limited to a single technical classification and a single reviewer. This focus suggests that the institute is currently prioritizing a specific botanical or biotechnology innovation for patent protection.
SEITZ, ANTHONY JOSEPH is the busiest examiner for the portfolio, managing the 1 pending office action. Because there is only 1 distinct examiner and 1 distinct art unit, the prosecution path is currently linear. The institute's immediate patent goals in the biotechnology space are tied to the resolution of this 1 pending office action. Practitioners should note that with only 1 distinct examiner involved, the success of the current filing depends entirely on addressing the specific concerns of that individual. The 1 distinct art unit involved will dictate the technical standards applied to the 1 pending office action. This concentration ensures that all current intellectual property efforts are directed through a single technical channel.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEITZ, ANTHONY JOSEPH | 1 | 67.8% | +27.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697959 | GUAIANOLIDE OLIGOMERS, PREPARATION METHOD AND APPLICATION | SEITZ, ANTHONY JOSEPH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697959 | GUAIANOLIDE OLIGOMERS, PREPARATION METHOD AND APPLICATION | SEITZ, ANTHONY JOSEPH | — |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18697959 | GUAIANOLIDE OLIGOMERS, PREPARATION METHOD AND APPLICATION | SEITZ, ANTHONY JOSEPH | 1629 | §101§112 | Non-Final OA | — | Pending | Apr 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKunming Institute Of Botany Chinese Academy Of Sciences has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Anthony Joseph Seitz has the most, with 1 of Kunming Institute Of Botany Chinese Academy Of Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
